Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
about
Muscle function in COPD: a complex interplayS-glutathionylation of troponin I (fast) increases contractile apparatus Ca2+ sensitivity in fast-twitch muscle fibres of rats and humansAntioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB Akt) signallingPulsed ultrasound associated with gold nanoparticle gel reduces oxidative stress parameters and expression of pro-inflammatory molecules in an animal model of muscle injury.Effects of low-level laser therapy (GaAs) in an animal model of muscular damage induced by trauma.Lipopolysaccharide-induced weakness in the preterm diaphragm is associated with mitochondrial electron transport chain dysfunction and oxidative stress.Ectopic catalase expression in mitochondria by adeno-associated virus enhances exercise performance in mice.The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis.Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress.IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force productionMechanisms of Myofascial PainThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy.Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model.Acute reduction of serum 8-iso-PGF2-alpha and advanced oxidation protein products in vivo by a polyphenol-rich beverage; a pilot clinical study with phytochemical and in vitro antioxidant characterization.Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.Skeletal muscle dysfunction is associated with derangements in mitochondrial bioenergetics (but not UCP3) in a rodent model of sepsis.Attenuation of cellular toxicity by calpain inhibitor induced by bacterial endotoxin: a mechanistic study using muscle precursor cells as a model system.Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weaknessMuscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatmentDoxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubesA Novel Noninvasive Method for Measuring Fatigability of the Quadriceps Muscle in Noncooperating Healthy Subjects.Ontogeny of proteolytic signaling and antioxidant capacity in fetal and neonatal diaphragmEffects of peripheral neuropathy on exercise capacity and quality of life in patients with chronic obstructive pulmonary diseases.IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties.Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.Stressed out: the skeletal muscle ryanodine receptor as a target of stressSkeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxideWeakness of whole muscles in mice deficient in Cu, Zn superoxide dismutase is not explained by defects at the level of the contractile apparatus.Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.Reactive oxygen species: impact on skeletal muscle.Sepsis-induced myopathy.Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target.Mechanical stretch-induced activation of ROS/RNS signaling in striated muscle.Clinical biomarkers in metabolic syndrome.ROS and RNS signaling in skeletal muscle: critical signals and therapeutic targets.
P2860
Q26865732-5D633710-FFE9-4F21-81AB-4E11B7C90589Q28257610-808F96FB-77BE-48F5-865D-692BD5CD9BEBQ28572937-07EA08D6-54C5-425B-9FB3-19E9C7C3FB33Q30468568-4FA3139C-DB85-4A3E-9DFD-707EFDE55261Q31049681-CB2C8449-F600-4817-AE91-B1A0C5EEFA7FQ31138969-E2010B52-AB90-4108-A908-1EDE66FABFA2Q33494824-B4B6DE90-97DD-4203-86C6-2D459A8E1561Q33623783-60611380-DC0F-4E13-A998-87F7EC4C06A2Q33751226-1A42E86D-58E7-404A-B71B-657511C1EED9Q33799514-D2E27657-20AF-438D-9E80-2EE501F4E101Q33802207-69D249C5-859C-4E6A-B742-58C49DB4DB2CQ34016655-9B2213A6-E06F-4955-AC34-8F76390C2332Q34457446-4E258246-A5CB-4B83-A7B8-A888D125DEB7Q34483183-CF834859-22EA-4BCD-87DE-23B7355E18A0Q34674995-431010E5-0EB8-4AE2-8CED-CD12F50DC10BQ34991641-099D1366-1481-496D-9092-063F1B27B694Q35122128-455CA45B-72C0-4BB0-83A8-AC488E339842Q35222202-27539AB5-C4C1-463B-B2F9-1924E41486C6Q35572934-0E8A820D-A525-4A7E-BC85-5E1BA9FEF7AEQ35587987-B83C0299-257A-432F-8755-CE209873DF0DQ35658078-80CA4D05-175A-4801-9265-8ADDFE9A2499Q35834462-84B5125C-D130-445C-A398-4ED18AD6F208Q35895750-A76603DA-A0DA-4377-B62C-E32D3F2E784FQ35912706-EB4725E0-C45E-489A-ACEC-D1191BBEB940Q35990053-A2D759F4-8F99-411E-9FCA-9E8011A3A911Q35990454-935EFA54-1FD7-4BBD-BC84-768292A5CC31Q36244747-C34DA204-5BFF-4AFA-9350-3AD8EB485E2BQ36267615-8D50C448-FEDB-4605-A953-05061C6B0A2FQ36407033-1A0DBBD2-FC54-4DF8-A144-E18CAD5D0B42Q36820423-9A79273A-FB68-4B0D-9E2D-45EF31D17E23Q36993421-D95C2E87-4ED2-43DA-AB46-8FB06593D411Q37154934-F1F5AF41-1545-47EF-A11F-FB82B8E1EF57Q37218019-AD16865F-5D1A-4047-848A-6A99F9EC3A50Q37384579-C6320475-429B-4932-B92E-74426C287A19Q37483737-67A10941-4424-4951-9287-A416FD0C3503Q37666348-659E5F84-9665-4C0B-B54F-84D3AD6A9945Q38078795-DB6014DA-90B0-4616-AAB0-D309B0979F87Q38131000-F9A5B853-260C-4205-B7CE-FC3F8D2124F7Q38171244-571C0094-816B-43F0-B229-0692072924BDQ38217375-94ABFDA1-7984-4331-B38A-867947605753
P2860
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@ast
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@en
type
label
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@ast
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@en
prefLabel
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@ast
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@en
P2860
P1476
Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
@en
P2093
Gerald S Supinski
Leigh A Callahan
P2860
P304
P356
10.1152/JAPPLPHYSIOL.01138.2006
P407
P577
2007-01-11T00:00:00Z